eSight. Innovation in vision enhancement
The eSight Story
Conrad Lewis had one goal – to help his two legally–blind sisters see. Both sisters live with Stargardt’s disease, a rare genetic disease that causes vision loss. The electrical engineer spent years tinkering with gadgets and bits of access software, all with the intent of creating a product that could help people living with visual impairments see, live independently and be truly mobile.
eSight is the result
Conrad knew that success would require a technological breakthrough that delivered instant sight and moved seamlessly with the wearer, while providing enhanced vision for activities of daily life. After years of research and development, and millions of dollars of investment, the first eSight Eyewear prototype was released in 2013, with additional product releases to follow, including eSight 3 and eSight 4.
Continued Innovation with Gentex Corporation
January 2022 – eSight partners with Gentex Corporation (NASDAQ: GNTX) to launch the next generation in vision enhancement technology. Gentex Corporation is a technology company and long-time supplier of electro-optical products for the global automotive, aerospace and fire protection industries.
November 2023 – Gentex Corporation (NASDAQ: GNTX) acquires eSight and continues to utilize its expertise in digital vision, software development and industrial design to develop eSight into the leading assistive digital device for people with low vision and central vision loss.
Awards and Accolades
About eSight
eSight by Gentex Corporation (NASDAQ: GNTX) is a pioneer in assistive digital vision technology and provides the most innovative and advanced device available for those with visual impairments. eSight digital low-vision device enhances vision for people with central vision loss caused by more than 20 different eye conditions, including Macular Degeneration, Diabetic Retinopathy, and Stargardt disease. TeleHealth is proven to significantly improve patient quality of life through multiple peer-reviewed randomized controlled trials (RCT).
eSight is a Class 1 medical device. eSight is licensed and inspected by Health Canada and registered with the US FDA and EUDAMED. Outside of North America, eSight is available from Authorized Representatives.
